Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WXS
|
|||
| Former ID |
DNC002728
|
|||
| Drug Name |
Homoserine Lactone
|
|||
| Synonyms |
homoserinium lactone; 2-oxooxolan-3-aminium; homoserinium lactone(1+); homoserinium lactone cation; (2-oxooxolan-3-yl)azanium; 2-oxotetrahydrofuran-3-aminium; AC1N129K
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H7NO2
|
|||
| Canonical SMILES |
C1COC(=O)C1N
|
|||
| InChI |
1S/C4H7NO2/c5-3-1-2-7-4(3)6/h3H,1-2,5H2
|
|||
| InChIKey |
QJPWUUJVYOJNMH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1192-20-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:17289
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium/hydrogen exchanger 1 (SLC9A1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | cAMP signaling pathway | |||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Regulation of actin cytoskeleton | ||||
| Thyroid hormone signaling pathway | ||||
| Salivary secretion | ||||
| Gastric acid secretion | ||||
| Pancreatic secretion | ||||
| Bile secretion | ||||
| Proteoglycans in cancer | ||||
| Pathway Interaction Database | Endothelins | |||
| RhoA signaling pathway | ||||
| ErbB1 downstream signaling | ||||
| Signaling mediated by p38-alpha and p38-beta | ||||
| Reactome | Hyaluronan uptake and degradation | |||
| WikiPathways | Regulation of Actin Cytoskeleton | |||
| G Protein Signaling Pathways | ||||
| Glycosaminoglycan metabolism | ||||
| Osteoclast Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.